Lifecode Raises $20.5 Million In Series A
By Dan Anderson ● Feb 24, 2015
Lifecode is next-generation-sequencing (NGS) based molecular diagnostics company that has raised $20.5 million Series A round led by Sequoia Capital, The Mayo Clinic, and Mayo Ventures.